PRKAA1 and myeloid leukemia: The concurrent activation of AMPK and mTORC1 was also described upon amino acid load [27], and in myeloid leukemia following treatment with the AMPK inducer (GSK621), which seems to enhance the unfolded protein response (UPR) [28].